| The B-side of cancer immunity: the underrated tune A Largeot, G Pagano, S Gonder, E Moussay, J Paggetti Cells 8 (5), 449, 2019 | 171 | 2019 |
| Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia R Aucagne, N Droin, J Paggetti, B Lagrange, A Largeot, A Hammann, ... The Journal of clinical investigation 121 (6), 2361-2370, 2011 | 140 | 2011 |
| Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells R Quéré, L Saint-Paul, V Carmignac, RZ Martin, ML Chrétien, A Largeot, ... Proceedings of the National Academy of Sciences 111 (29), 10592-10597, 2014 | 74 | 2014 |
| Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells J Paggetti, A Largeot, R Aucagne, A Jacquel, B Lagrange, XJ Yang, ... Oncogene 29 (36), 5019-5031, 2010 | 69 | 2010 |
| A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages B Lagrange, RZ Martin, N Droin, R Aucagne, J Paggetti, A Largeot, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (8), 1936-1946, 2013 | 63 | 2013 |
| Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac AJ Lilly, G Costa, A Largeot, MZH Fadlullah, M Lie-A-Ling, G Lacaud, ... Development 143 (23), 4341-4351, 2016 | 39 | 2016 |
| Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses E Gargiulo, E Viry, PE Morande, A Largeot, S Gonder, F Xian, N Ioannou, ... Blood cancer discovery 4 (1), 54-77, 2023 | 24 | 2023 |
| Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced … H Wurzer, L Filali, C Hoffmann, M Krecke, AM Biolato, J Mastio, ... Frontiers in Immunology 12, 619069, 2021 | 21 | 2021 |
| Diagnostic and therapeutic potential of extracellular vesicles in B-cell malignancies E Gargiulo, PE Morande, A Largeot, E Moussay, J Paggetti Frontiers in oncology 10, 580874, 2020 | 21 | 2020 |
| Expression of the MOZ-TIF2 oncoprotein in mice represses senescence A Largeot, FM Perez-Campo, E Marinopoulou, M Lie-a-Ling, V Kouskoff, ... Experimental Hematology 44 (4), 231-237. e4, 2016 | 19 | 2016 |
| Method for the analysis of the tumor microenvironment by mass cytometry: application to chronic lymphocytic leukemia S Gonder, I Fernandez Botana, M Wierz, G Pagano, E Gargiulo, A Cosma, ... Frontiers in Immunology 11, 578176, 2020 | 18 | 2020 |
| Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice ML Chrétien, C Legouge, RZ Martin, A Hammann, M Trad, R Aucagne, ... Experimental hematology 44 (8), 727-739. e6, 2016 | 18 | 2016 |
| Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL A Largeot, V Klapp, E Viry, S Gonder, I Fernandez Botana, A Blomme, ... Blood, The Journal of the American Society of Hematology 141 (26), 3166-3183, 2023 | 10 | 2023 |
| Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia G Pagano, IF Botana, M Wierz, PM Roessner, N Ioannou, X Zhou, ... Haematologica 108 (11), 3011, 2023 | 8 | 2023 |
| Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells A Largeot, J Paggetti, J Broséus, R Aucagne, B Lagrange, RZ Martin, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (12), 3054-3063, 2013 | 7 | 2013 |
| The tumor microenvironment-dependent transcription factors AHR and HIF-1α are dispensable for leukemogenesis in the eµ-TCL1 mouse model of chronic lymphocytic leukemia S Gonder, A Largeot, E Gargiulo, S Pierson, I Fernandez Botana, ... Cancers 13 (18), 4518, 2021 | 6 | 2021 |
| Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia V Klapp, J Paggetti, A Largeot, E Moussay Cancer Communications 43 (12), 1373, 2023 | 1 | 2023 |
| The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency M Sheridan, MA Maqbool, A Largeot, L Clayfield, J Xu, N Moncaut, ... Journal of Hematology & Oncology 17 (1), 91, 2024 | | 2024 |
| Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia C Sauter, T Morin, F Guidez, J Simonet, C Fournier, C Row, D Masnikov, ... Communications Biology 7 (1), 753, 2024 | | 2024 |
| Protein Arginine Methyltransferase 2 is involved in the control of inflammatory processes in acute myeloid leukemia C Sauter, T Morin, F Guidez, J Simonet, C Fournier, C Row, D Masnikov, ... Cancer Research 84 (6_Supplement), 5588-5588, 2024 | | 2024 |
